Status:
COMPLETED
Initial Combination With Pioglitazone Study (0431-064)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A clinical study to evaluate the safety and efficacy of the initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes mellitus not on treatment with insulin or ora...
Eligibility Criteria
Inclusion
- General
- Patients ≥18 years old with Type 2 Diabetes Mellitus (a specific type of diabetes)
- General
Exclusion
- Patient has a history of type 1 diabetes mellitus or history of ketoacidosis
- Patient was on antihyperglycemic agent therapy (oral or insulin) within the prior 4 months
- Patient was on \>4 weeks (cumulatively) of antihyperglycemic therapy (oral or insulin) over the prior 2 years
Key Trial Info
Start Date :
December 19 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2008
Estimated Enrollment :
520 Patients enrolled
Trial Details
Trial ID
NCT00397631
Start Date
December 19 2006
End Date
June 28 2008
Last Update
May 12 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.